f105

mAbexperimental

The Republic F-105 Thunderchief is an American fighter-bomber that served with the United States Air Force from 1958 to 1984. Capable of Mach 2, it conducted the majority of strike bombing missions during the early years of the Vietnam War. It was originally designed as a single-seat, nuclear-attack aircraft; a two-seat Wild Weasel version was later developed for the specialized Suppression of Enemy Air Defenses (SEAD) role against surface-to-air missile sites. The F-105 was commonly known as the "Thud" by its crews. It is the only American aircraft to have been removed from combat due to high loss rates. — Wikipedia

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Nov 2, 1999 (NCT00001105)

Timeline

1990s

  1. Jan 1, 1999

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • f105
  • f105
  • f105

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00001105Phase 1Nov 2, 1999National Institute of Allergy and Infectious Diseases (NIAID)
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Institute of Allergy and Infectious Diseases (NIAID)Government1111999
1 organizations
Page 1 / 1